{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:27:14Z","timestamp":1783488434224,"version":"3.55.0"},"reference-count":34,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej15-0492","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T22:13:57Z","timestamp":1449094437000},"page":"179-185","source":"Crossref","is-referenced-by-count":17,"title":["Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves&amp;rsquo; disease"],"prefix":"10.1507","volume":"63","author":[{"given":"Waka","family":"Yoshioka","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tamai","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kihara","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Miya","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Amino","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zimmerman D (1999) Fetal and neonatal hyperthyroidism. <i>Thyroid<\/i> 9: 727-733.","DOI":"10.1089\/thy.1999.9.727"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McKenzie JM, Zakarija M (1992) Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. <i>Thyroid <\/i>2: 155-159.","DOI":"10.1089\/thy.1992.2.155"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, <i>et al<\/i>. (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. <i>Thyroid<\/i> 21: 1081-1125.","DOI":"10.1089\/thy.2011.0087"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chan GW, Mandel SJ (2007) Therapy insight: management of Graves&rsquo; disease during pregnancy. <i>Nat Clin Pract Endocrinol Metab<\/i> 3: 470-478.","DOI":"10.1038\/ncpendmet0508"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, <i>et al.<\/i> (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. <i>J Clin Endocrinol Metab<\/i> 97: 2543-2565.","DOI":"10.1210\/jc.2011-2803"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tamaki H, Amino N, Aozasa M, Mori M, Iwatani Y, <i>et al. <\/i>(1988) Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. <i>Am J Perinatol<\/i> 5: 152-158.","DOI":"10.1055\/s-2007-999676"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takamura Y, Nakano K, Uruno T, Ito Y, Miya A, <i>et al.<\/i> (2003) Changes in serum TSH receptor antibody (TRAb) values in patients with Graves&rsquo; disease after total or subtotal thyroidectomy. <i>Endocr J<\/i> 50: 595-601.","DOI":"10.1507\/endocrj.50.595"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Amino N, Kubota S, Morita S, Fukata S, Miyauchi A (2007) Quantitative measurement of anti-TSH receptor antibodies is useful for the evaluation of treatment effect. <i>Thyroid<\/i> 17: 85-86.","DOI":"10.1089\/thy.2006.0245"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yoshimura Noh J, Miyazaki N, Ito K, Takeda K, Hiramatsu S, <i>et al.<\/i> (2008) Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. <i>Thyroid<\/i> 18: 1157-1164.","DOI":"10.1089\/thy.2008.0119"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical&nbsp;activity&nbsp;score as a guide in the management of patients with Graves&rsquo; ophthalmopathy. <i>Clin Endocrinol (Oxf)<\/i> 47: 9-14.","DOI":"10.1046\/j.1365-2265.1997.2331047.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, <i>et al. <\/i>(1996) Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves&rsquo; disease after subtotal thyroidectomy. <i>World J Surg <\/i>20: 801-807","DOI":"10.1007\/s002689900122"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nart A, Uslu A, Aykas A, Yuzbasioglu F, Dogan M, <i>et al. <\/i>(2008) Total thyroidectomy for the treatment of recurrent graves&rsquo; disease with ophthalmopathy. <i>Asian J Surg<\/i> 31: 115-118.","DOI":"10.1016\/S1015-9584(08)60070-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, <i>et al<\/i>. (2012) Time course of Graves&rsquo; ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. <i>Endocrine<\/i> 41: 320-326.","DOI":"10.1007\/s12020-011-9559-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Van der Weerd K, Van Hagen PM, Schrijver B, Kwekkeboom DJ, De Herder WW, <i>et al<\/i>. (2013) The peripheral blood compartment in patients with Graves&rsquo; disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes. <i>Clin Exp Immunol<\/i> 174: 256-264.","DOI":"10.1111\/cei.12183"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kamijo K (2007) TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves&rsquo; disease. <i>Endocr J<\/i> 54: 619-624.","DOI":"10.1507\/endocrj.K06-196"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Amino N, Izumi Y, Hidaka Y, Takeoka K, Nakata Y, <i>et al<\/i>. (2003) No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves&rsquo; disease. <i>J Clin Endocrinol Metab<\/i> 88: 5871-5874.","DOI":"10.1210\/jc.2003-030971"},{"key":"17","unstructured":"17. Gonzalez-Jimenez A, Fernandez-Soto ML, Escobar-Jimenez F, Glinoer D, Navarrete L (1993) Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves&rsquo; disease patients: a sequential study before, during and after pregnancy. <i>Thyroidology <\/i>5: 13-20."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hamada N, Momotani N, Ishikawa N, Yoshimura Noh J, Okamoto Y, <i>et al<\/i>. (2011) Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism. <i>Endocr J<\/i> 58: 55-58.","DOI":"10.1507\/endocrj.K10E-123"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Matsumoto T, Miyakoshi K, Saisho Y, Ishii T, Ikenoue S, <i>et al<\/i>. (2013) Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy. <i>Endocr J<\/i> 60: 1281-1287.","DOI":"10.1507\/endocrj.EJ13-0248"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gietka-Czernel M, Debska M, Kretowicz P, Zgliczynski W, Oltarzewski M (2014) Hyperthyroidism during pregnancy&mdash;the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring. <i>Endokrynol Pol<\/i> 65: 259-268.","DOI":"10.5603\/EP.2014.0035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zuppa AA, Sindico P, Savarese I, D&rsquo;Andrea V, Fracchiolla A, <i>et al<\/i>. (2007) Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy. <i>J Pediatr Endocrinol Metab <\/i>20: 535-539.","DOI":"10.1515\/JPEM.2007.20.4.535"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tamaki H, Amino N, Aozasa M, Mori M, Iwatani Y, <i>et al<\/i>. (1988) Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. <i>Am J Perinatol<\/i> 5: 152-158.","DOI":"10.1055\/s-2007-999676"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jang SY, Shin DY, Lee EJ, Lee SY, Yoon JS (2013) Relevance of TSH-receptor antibody levels in predicting disease course in Graves&rsquo; orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay. <i>Eye (Lond)<\/i> 27: 964-971.","DOI":"10.1038\/eye.2013.120"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tvito-Green R, Reich E, Robenshtok E, Chodick G, Ron-Kella Y (2014) Third-generation ELISA thyrotropin-receptor antibody levels as an adjuvant tool to guide management of patients with graves orbitopathy. <i>Endocr Pract <\/i>20: 145-149.","DOI":"10.4158\/EP13164.OR"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lantz M, Planck T, Asman P, Hallengren B (2014) Increased TRAb and\/or low anti-TPO titers at diagnosis of graves&rsquo; disease are associated with an increased risk of developing ophthalmopathy after onset. <i>Exp Clin Endocrinol Diabetes <\/i>122: 113-117.","DOI":"10.1055\/s-0033-1363193"},{"key":"26","unstructured":"26. Eckstein A, Esser J, Mann K, Schott M (2010) Clinical value of TSH receptor antibodies measurement in patients with Graves&rsquo; orbitopathy. <i>Pediatr Endocrinol Rev <\/i>7 Suppl 2: 198-203."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, <i>et al<\/i>. (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves&rsquo; ophthalmopathy and help to predict severity and outcome of the disease. <i>J Clin Endocrinol Metab<\/i> 91: 3464-3470.","DOI":"10.1210\/jc.2005-2813"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Quadbeck B, Roggenbuck U, Janssen OE, Hahn S, Mann K, <i>et al<\/i>. (2006) Impact of smoking on the course of Graves&rsquo; disease after withdrawal of antithyroid drugs. <i>Exp Clin Endocrinol Diabetes<\/i> 114: 406-411.","DOI":"10.1055\/s-2006-924065"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell&rsquo;Unto E, <i>et al<\/i>. (1998) Cigarette smoking and treatment outcomes in Graves ophthalmopathy. <i>Ann Intern Med <\/i>129: 632-635.","DOI":"10.7326\/0003-4819-129-8-199810150-00010"},{"key":"30","unstructured":"30. Chng CL, Lai OF, Chew CS, Peh YP, Fook-Chong SM, <i>et al<\/i>. (2014) Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves&rsquo; ophthalmopathy. <i>Int J Ophthalmol<\/i> 7: 403-407."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Thornton J, Kelly SP, Harrison RA, Edwards R (2007) Cigarette smoking and thyroid eye disease: a systematic review. <i>Eye (Lond)<\/i> 21: 1135-1145.","DOI":"10.1038\/sj.eye.6702603"},{"key":"32","unstructured":"32. Bartalena L, Pinchera A, Marcocci C (2000) Management of Graves&rsquo; ophthalmopathy: reality and perspectives. <i>Endocr Rev<\/i> 21: 168-199."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves&rsquo; disease and ophthalmopathy. <i>Endocr Rev<\/i> 24: 802-835.","DOI":"10.1210\/er.2002-0020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Bartalena L, Marcocci C, Pinchera A (2002) Graves&rsquo; ophthalmopathy: a preventable disease? <i>Eur J Endocrinol<\/i> 146: 457-461.","DOI":"10.1530\/eje.0.1460457"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/2\/63_EJ15-0492\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T03:06:18Z","timestamp":1653707178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/2\/63_EJ15-0492\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0492","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}